IN VITRO EVALUATION OF ANTICANCER POTENTIAL OF ERYTHRINA VARIEGATA L. ON BREAST CANCER CELL LINES

  • Vaishali Rai M Department of Biochemistry, Yenepoya Medical College, Yenepoya University, Mangalore, Karnataka, India.
  • Vinitha Ramanath Pai Department of Biochemistry, Yenepoya Medical College, Yenepoya University, Mangalore, Karnataka, India.
  • Samuel Kevin Department of Biochemistry, Yenepoya Medical College, Yenepoya University, Mangalore, Karnataka, India.
  • Herga P Kedilaya Department of Biochemistry, Srinivas Institute of Medical Sciences and Research Centre, Mangalore, Karnataka, India.

Abstract

Objective: Species of Erythrina variegata L. is reported to be used in the treatment of cancer in traditional/folklore medicine which could be explored for their anticancer potential. We aimed to evaluate the anticancer activity of crude extracts of the leaves of E. variegata with two solvents; explore the mechanism of cytotoxicity with the effective extract and correlation with the phytochemicals in the extract.

Methods: The extracts with Erythrina variegata L methanol (EVM) and chloroform (EVC) as solvents were screened for cytotoxicity by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium assay on MDA-MB-231 and MCF-7 cell lines. The effective extract was further evaluated on MDA-MB-231 cells by nucleoprotein content estimation, and cell morphology was studied. High resolution liquid chromatography mass spectrometry (HRLCMS) of EVM was done to find the phytochemical composition.

Results: Among the two extracts, EVM was effective at an inhibitory concentration (IC50) value of 92 μg/ml and 143 μg/ml on MCF-7 and MDA-MB-231 cells, respectively. At the IC50 value (143 μg/ml) the nucleoprotein content of the cells was 58.2%, and the apoptotic index was calculated to be 51.8%. EVM treated group showed significant morphological changes suggestive of apoptosis. HRLCMS revealed the presence of rutin, podocarpatriene, and cepharanthine which are known to be cytotoxic.

Conclusion: This report is a contribution toward the validation of E. variegata as a potential source of anticancer agents.

Keywords: Erythrina variegata, Cytotoxicity, Apoptosis, MDA-MB-231, Podocarpatriene.

Author Biographies

Vaishali Rai M, Department of Biochemistry, Yenepoya Medical College, Yenepoya University, Mangalore, Karnataka, India.
Research scholar, Dept. of Biochemistry
Vinitha Ramanath Pai, Department of Biochemistry, Yenepoya Medical College, Yenepoya University, Mangalore, Karnataka, India.
Professor, Dept. of Biochemistry
Samuel Kevin, Department of Biochemistry, Yenepoya Medical College, Yenepoya University, Mangalore, Karnataka, India.
Intern, Yenepoya Medical college
Herga P Kedilaya, Department of Biochemistry, Srinivas Institute of Medical Sciences and Research Centre, Mangalore, Karnataka, India.
Professor & HOD, Dept of Biochemistry

References

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin 2007;57(1):43-66.
2. Bray F, Møller B. Predicting the future burden of cancer. Nat Rev Cancer 2006;6(1):63-74.
3. Sen U, Sankaranarayanan R, Mandal S, Ramanakumar AV, Parkin DM, Siddiqi M. Cancer patterns in eastern India: The first report of the Kolkata cancer registry. Int J Cancer 2002;100(1):86-91.
4. Hedenfalk IA, Ringnér M, Trent JM, Borg A. Gene expression in inherited breast cancer. Adv Cancer Res 2002;84:1-34.
5. Ingrasson S. Breast cancer: Introduction. Semin Cancer Biol 2001;11:323-6.
6. Dobashi Y, Takehana T, Ooi A. Perspectives on cancer therapy: Cell cycle blockers and perturbators. Curr Med Chem 2003;10(23):2549-58.
7. Fan S, Cherney B, Reinhold W, Rucker K, O’Connor PM. Disruption of p53 function in immortalized human cells does not affect survival or apoptosis after taxol or vincristine treatment. Clin Cancer Res 1998;4(4):1047-54.
8. Garrett MD. Cell cycle control and cancer. Curr Sci 2001;81:515-22.
9. Merlin NJ, Parthasarthy V, Santhoshkumar TR. Induction of apoptosis in human breast cancer cell line MCF-7 by phytochemicals from Gmelina asiatica. Afr J Biotechnol 2010;9:4451-6.
10. Sandal T. Molecular aspects of the mammalian cell cycle and cancer. Oncologist 2002;7(1):73-81.
11. Tachibana KE, Gonzalez MA, Coleman N. Cell-cycle-dependent regulation of DNA replication and its relevance to cancer pathology. J Pathol 2005;205:123-9.
12. Jahan R, Hossain S, Seraj S, Nasrin D, Khatun Z, Ranidas P, et al. Centella asiatica (L.) Urb.: Ethnomedicinal uses and their scientific validations. Am Eur J Sustain Agric 2012;6:261-70.
13. Amri E. The role of selected plant families with dietary ethnomedical species used as anticancer. J Med Plants Stud 2014;2:28-39.
14. Nkengfack AE, Azebaze AG, Waffo AK, Fomum ZT, Meyer M, van Heerden FR. Cytotoxic isoflavones from Erythrina indica. Phytochemistry 2001;58(7):1113-20.
15. Baskar N, Parimaladevi B, Mohankumar R. Evaluation of anticancer activity of methanol extract of root bark of Erythrina variegata Linn. J Pharm Res 2010;3:1724-5.
16. Hartwell JL. Plants used against cancer. A survey. Lloydia 1970;33(4):288-392.
17. Rahman MZ, Sultana SJ, Faruquee CF, Ferdous F, Rahman MS, Islam MS, et al. Phytochemical and biological investigations of Erythrina variegata. Saudi Pharm J 2007;15:140-5.
18. Suryawanshi HP, Patel MR. Traditional uses, medicinal and phytopharmacological properties of E. Indica Lam: An overview. Int J Res Ayurveda Pharm 2011;2:1531-3.
19. Mosmann T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods 1983;65(1-2):55-63.
20. Denizot F, Lang R. Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J Immunol Methods 1986;89(2):271-7.
21. Gillies RJ, Didier N, Denton M. Determination of cell number in monolayer cultures. Anal Biochem 1986;159(1):109-13.
22. Vidhya N, Devaraj SN. Induction of apoptosis by eugenol in human breast cancer cells. Indian J Exp Biol 2011;49(11):871-8.
23. Harborne JB. Phytochemical Methods. London: Chapman and Hall; 1973.
24. Dampier K, Hudson EA, Howells LM, Manson MM, Walker RA, Gescher A. Differences between human breast cell lines in susceptibility towards growth inhibition by genistein. Br J Cancer 2001;85(4):618-24.
25. Herlina T, Nurlelasari DK, Supratman U, Zalinar U. In vitro anti-cancer and antimalarial erystagallin a from Erythrina variegata (Leguminoseae) stem bark. Int J Phytomed Relat Ind 2001;1:9-13.
26. Elgadir AM, Salama M, Adam A. Anti-breast cancer from various natural sources-review. Int J Pharm Pharm Sci 2015;7:44-7.
27. Morse DL, Gray H, Payne CM, Gillies RJ. Docetaxel induces cell death through mitotic catastrophe in human breast cancer cells. Mol Cancer Ther 2005;4(10):1495-504.
28. Lowe SW, Lin AW. Apoptosis in cancer. Carcinogenesis 2000;21(8):485-95.
29. Heber D. Vegetables, fruits and phytoestrogens in the prevention of diseases. J Postgrad Med 2004;50(2):145-9.
30. Taraphdar AK, Roy M, Bhattacharya RK. Natural products as inducers of apoptosis: Implication for cancer therapy and prevention. Curr Sci 2001;80:1387-96.
31. Haris M, Mahmood R, Rahman H, Rahman N. In vitro cytotoxic activity of Clerodendrum infortunatum L. Against T47D, PC-3, A549 and HCT-116 human cancer cell lines and its phytochemical screening. Int J Pharm Pharm Sci 2016;8:439-44.
32. Deschner EE, Ruperto J, Wong G, Newmark HL. Quercetin and rutin as inhibitors of azoxymethanol-induced colonic neoplasia. Carcinogenesis 1991;12(7):1193-6.
33. Ravindranath N, Ravinder Reddy M, Ramesh C, Ramu R, Prabhakar A, Jagadeesh B, et al. New lathyrane and podocarpane diterpenoids from Jatropha curcas. Chem Pharm Bull (Tokyo) 2004;52(5):608-11.
34. Furusawa S, Wu J, Fujimura T, Nakano S, Nemoto S, Takayanagi M, et al. Cepharanthine inhibits proliferation of cancer cells by inducing apoptosis. Methods Find Exp Clin Pharmacol 1998;20(2):87-97.
Statistics
399 Views | 381 Downloads
Citatons
How to Cite
M, V. R., V. R. Pai, S. Kevin, and H. P. Kedilaya. “IN VITRO EVALUATION OF ANTICANCER POTENTIAL OF ERYTHRINA VARIEGATA L. ON BREAST CANCER CELL LINES”. Asian Journal of Pharmaceutical and Clinical Research, Vol. 10, no. 7, July 2017, pp. 305-10, doi:10.22159/ajpcr.2017.v10i7.18409.
Section
Original Article(s)